Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building ...
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.
Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
A study by the Neuropsychopharmacology and IBeA groups of the University of the Basque Country (UPV/EHU) paves the way to ...
DMR News on MSN2d
Google Unveils Open AI Models for Accelerating Drug DiscoveryDuring a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...
The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...
Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
Monte Rosa announced clinical results from its MRT-6160 Phase 1, single ascending dose / multiple ascending dose study. Details about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback